Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | -8,590 | -13,460 | -2,390 | N/A |
| Depreciation Amortization | 0 | 1,760 | 1,280 | 250 | N/A |
| Other Working Capital | 0 | 1,430 | 3,070 | -1,310 | N/A |
| Other Operating Activity | 0 | 580 | -630 | 940 | 0 |
| Operating Cash Flow | $0 | $-4,820 | $-9,740 | $-2,510 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -1,380 | -1,110 | -1,260 | N/A |
| Net Acquisitions | 0 | 0 | 2,370 | 0 | N/A |
| Other Investing Activity | 0 | 4,920 | 2,460 | 0 | 0 |
| Investing Cash Flow | $0 | $3,540 | $3,720 | $-1,260 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 7 | 9,360 | 18,800 | 0 |
| Financing Cash Flow | $0 | $7 | $9,360 | $18,800 | $N/A |
| Exchange Rate Effect | 0 | -320 | 1,650 | -740 | N/A |
| Beginning Cash Position | 0 | 23,070 | 19,750 | 5,300 | N/A |
| End Cash Position | 0 | 21,470 | 24,750 | 19,580 | N/A |
| Net Cash Flow | $0 | $-1,600 | $4,990 | $14,270 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | -4,820 | -9,740 | -2,510 | N/A |
| Free Cash Flow | 0 | -4,820 | -9,740 | -2,510 | 0 |